Buy & Sell Novartis AG (NVS) – Novartis AG Price Today
Aura AI Summary
Key Stats
- $276.29BMarket Cap
- HealthSector
- -15.23%3M Drawdown
- $316.32BEnterprise Value
- 3.26%Dividend Yield
- 2% Buy | 98% SellTrading Activity
- 80 daysTypical Hold Time
Novartis AG (NVS) is currently valued at a market capitalization of $276.29B, with an enterprise value of $316.32B. Over the past 52 weeks, Novartis AG has traded between a low of $104.99 and a high of $168.62, highlighting its annual price range. Over the past three months, Novartis AG has recorded a drawdown of -15.23%, reflecting recent price volatility. Novartis AG offers a dividend yield of 3.26%, with the most recent dividend of $4.77 paid on 11 Mar 26. On average, investors hold Novartis AG for approximately 80 days, indicating typical investor behavior on the platform.
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Most Recent News
ENR FutureTech 2026 sets record attendance, showcasing robotics and AI transforming construction industry.
ENR FutureTech 2026, the leading construction technology conference, concluded with record attendance and sold-out sponsorships, highlighting innovations like autonomous excavators and AI-driven project management. Industry leaders and tech innovator...
Halper Sadeh LLC investigates fairness of deals for HLX, OGN, XOMA, and RMAX shareholders.
Halper Sadeh LLC is investigating whether shareholders of Helix Energy Solutions (HLX), Organon & Co. (OGN), XOMA Royalty Corporation (XOMA), and RE/MAX Holdings (RMAX) are receiving fair treatment in their companies' recent mergers and sales. The fi...
Snap and Perplexity end AI integration plans for Snapchat, citing misaligned product goals.
Snap and Perplexity have mutually ended their partnership to integrate Perplexity's AI answer engine into Snapchat, as the collaboration did not align with their product goals. Initially announced in November 2025, the deal involved Perplexity paying...